Coumarinyl pyrazole derivatives of INH: promising antimycobacterial agents
摘要:
The purpose of this study was to evaluate the antimycobacterial activity of various pyrazole derivatives derived from the isoniazid pharmacophore along with coumarin scaffold. The synthesized title compounds (4a-4k) were investigated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv using Resazurin MIC assay. The synthesized compounds exhibited MIC ranging from 0.625 to 2.50 mu g/ml. Among the series tested, compound 3-[3-(4-fluorophenyl)-1-isonicotinoyl-1H-pyrazol-5-yl]-2H-chromen-2-one 4i was found to be the most active with MIC of 0.625 mu g/ml.
Synthesis and Antibacterial Activity of a New Series of 3&hyphen;&lsqb;3&hyphen;&lpar;Substituted Phenyl&rpar;&hyphen;1&hyphen;Isonicotinoyl&hyphen;1<i>H</i>&hyphen;Pyrazol&hyphen;5&hyphen;yl&rsqb;&hyphen;2<i>H</i>&hyphen;Chromen&hyphen;2&hyphen;one Derivatives
A novel series of 3‐[3‐(substituted phenyl)‐1‐isonicotinoyl‐1H‐pyrazol‐5‐yl]‐2H‐chromen‐2‐one derivatives 4a–k have been synthesized by the reaction of 3‐[2,3‐dibromo‐3‐(substituted phenyl) propanoyl]‐2H‐chromen‐2‐one 3a–k and isonicotinic acid hydrazide in the presence of triethylamine in absolute ethanol, characterized by spectral data and screened for their in‐vitro antibacterialactivity against